“novartis-venture-fund” Archives

in
Entry Author Date Location
Rox Medical Obtains $40,000,000 Series E Funding Round 09/07/16 San Diego
Annexon Biosciences Lands $44,000,000 Series B Funding Round 06/23/16 San Francisco
IFM Therapeutics Receives $27,000,000 Series A Round 06/23/16 Boston
Caribou Biosciences Secures $30,000,000 Series B Funding Round 05/16/16 San Francisco
Viamet Revisits IPO Plans, This Time With More Data 04/11/16 Raleigh Durham
West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More 01/29/16 San Diego
Adicet Bio Obtains $51,000,000 Series A Funding 01/28/16 San Francisco
Proteostasis Therapeutics Lands $37,000,000 Series B Funding 09/09/15 Boston
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
Ra Pharmaceuticals Receives $58,500,000 Series B Round 07/23/15 Boston
Innocrin Pharmaceuticals Lands $28M for Prostate, Breast Cancer Trials 04/15/15 Raleigh Durham
Austin’s Aeglea Biotherapeutics Raises $44M for Cancer Drug 03/23/15 Texas
Antibiotics Startup Gets $22M From Roche, Others, For New “Macrolides” 03/04/15 Boston
BioNano Raises $53M to Identify “Structural Variations” in Genome 11/20/14 San Diego
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More 02/28/14 San Diego
Thesan Pharmaceuticals Secures $49,000,000 Series B Financing 02/25/14 San Diego
Aileron Therapeutics Garners $30,000,000 Series E Funding Round 11/18/13 Boston
Akebia Therapeutics Receives $41,000,000 Series C Round 06/05/13 Detroit Ann Arbor
eFFECTOR Therapeutics Lands $45,000,000 Series A Funding 05/21/13 San Diego
Tokai Pharmaceuticals Obtains $35,500,000 Series E Round 05/15/13 Boston
Strategies for Navigating the Life Sciences Capital Crunch 04/15/13 San Francisco
Tokai Looks to Follow Fast Behind J&J, Medivation in Prostate Cancer 02/13/13 Boston
Aileron Therapeutics Garners $12,000,000 Series D Financing 01/14/13 Boston
Thesan Pharmaceuticals Receives $16,000,000 Series A Round 11/01/12 San Diego
Neurovance Raises $7 Million for ADHD Drug Development 10/19/12 Boston
Pulmatrix Names Clarke CEO, Releases Promising Data on Lung Drug 09/04/12 Boston
Ra Pharmaceuticals Receives $8,600,000 Series A Financing Round 05/16/12 Boston
Sonitus Medical Obtains $25,000,000 Series D Financing 05/15/12 San Francisco
ImaginAb Secures $12,500,000 Series A Funding Round 03/28/12 San Diego
Page 1 of 3 next page »